CST2 expression reportedly promoted tumor progression by activating the PI3K/AKT pathway in pancreatic cancer54 and was also associated with disease progression in colon cancer,55 prostate cancer,56 and gastric cancer.57 Here, CST2 is linked to prostate cancer.